Zimmer Biomet Holdings Statistics
Total Valuation
ZBH has a market cap or net worth of $16.03 billion. The enterprise value is $23.11 billion.
Important Dates
The next confirmed earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
ZBH has 193.57 million shares outstanding. The number of shares has decreased by -2.25% in one year.
| Current Share Class | 193.57M |
| Shares Outstanding | 193.57M |
| Shares Change (YoY) | -2.25% |
| Shares Change (QoQ) | -1.16% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 104.29% |
| Float | 192.98M |
Valuation Ratios
The trailing PE ratio is 21.47 and the forward PE ratio is 9.60. ZBH's PEG ratio is 1.67.
| PE Ratio | 21.47 |
| Forward PE | 9.60 |
| PS Ratio | 1.91 |
| Forward PS | 1.86 |
| PB Ratio | 1.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.09 |
| P/OCF Ratio | 9.60 |
| PEG Ratio | 1.67 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.00, with an EV/FCF ratio of 20.28.
| EV / Earnings | 30.36 |
| EV / Sales | 2.75 |
| EV / EBITDA | 9.00 |
| EV / EBIT | 15.85 |
| EV / FCF | 20.28 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.59.
| Current Ratio | 1.73 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 2.84 |
| Debt / FCF | 6.56 |
| Interest Coverage | 4.94 |
Financial Efficiency
Return on equity (ROE) is 6.06% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | 6.06% |
| Return on Assets (ROA) | 4.06% |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | 7.34% |
| Weighted Average Cost of Capital (WACC) | 6.26% |
| Revenue Per Employee | $494,653 |
| Profits Per Employee | $44,776 |
| Employee Count | 17,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.12 |
Taxes
In the past 12 months, ZBH has paid $142.20 million in taxes.
| Income Tax | 142.20M |
| Effective Tax Rate | 15.75% |
Stock Price Statistics
The stock price has decreased by -18.43% in the last 52 weeks. The beta is 0.61, so ZBH's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -18.43% |
| 50-Day Moving Average | 93.36 |
| 200-Day Moving Average | 95.08 |
| Relative Strength Index (RSI) | 28.63 |
| Average Volume (20 Days) | 2,323,244 |
Short Selling Information
The latest short interest is 10.09 million, so 5.21% of the outstanding shares have been sold short.
| Short Interest | 10.09M |
| Short Previous Month | 8.02M |
| Short % of Shares Out | 5.21% |
| Short % of Float | 5.23% |
| Short Ratio (days to cover) | 5.11 |
Income Statement
In the last 12 months, ZBH had revenue of $8.41 billion and earned $761.20 million in profits. Earnings per share was $3.86.
| Revenue | 8.41B |
| Gross Profit | 5.89B |
| Operating Income | 1.46B |
| Pretax Income | 902.90M |
| Net Income | 761.20M |
| EBITDA | 2.57B |
| EBIT | 1.46B |
| Earnings Per Share (EPS) | $3.86 |
Full Income StatementBalance Sheet
The company has $424.20 million in cash and $7.47 billion in debt, giving a net cash position of -$7.05 billion or -$36.40 per share.
| Cash & Cash Equivalents | 424.20M |
| Total Debt | 7.47B |
| Net Cash | -7.05B |
| Net Cash Per Share | -$36.40 |
| Equity (Book Value) | 12.68B |
| Book Value Per Share | 65.03 |
| Working Capital | 2.10B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.67 billion and capital expenditures -$534.20 million, giving a free cash flow of $1.14 billion.
| Operating Cash Flow | 1.67B |
| Capital Expenditures | -534.20M |
| Depreciation & Amortization | 1.11B |
| Net Borrowing | 144.00M |
| Free Cash Flow | 1.14B |
| FCF Per Share | $5.89 |
Full Cash Flow StatementMargins
Gross margin is 70.03%, with operating and profit margins of 17.34% and 9.05%.
| Gross Margin | 70.03% |
| Operating Margin | 17.34% |
| Pretax Margin | 10.74% |
| Profit Margin | 9.05% |
| EBITDA Margin | 30.53% |
| EBIT Margin | 17.34% |
| FCF Margin | 13.55% |